Publikationen in Zusammenarbeit mit Forschern von Universidad de Málaga (10)

2023

  1. Generation of heart and vascular system in rodents by blastocyst complementation

    Developmental Cell, Vol. 58, Núm. 24, pp. 2881-2895.e7

2021

  1. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

    Acta Biomaterialia, Vol. 126, pp. 394-407

  2. Extracellular vesicle-based therapeutics for heart repair

    Nanomaterials, Vol. 11, Núm. 3, pp. 1-30

2020

  1. Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction

    Circulation, Vol. 142, Núm. 19, pp. 1831-1847

2019

  1. Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

    Nature, Vol. 569, Núm. 7756, pp. 428-432

2018

  1. Bmi1-progenitor cell ablation impairs the angiogenic response to myocardial infarction

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 38, Núm. 9, pp. 2160-2173

2016

  1. La aplicación de un protocolo de gestión para la hemorragia masiva reduce la mortalidad en pacientes con hemorragia no traumática: Resultados de la auditoría de un centro

    Medicina Intensiva, Vol. 40, Núm. 9, pp. 550-559

2015

  1. Foro de debate: Seguridad de las alternativas a la transfusión alogénica en el paciente quirúrgico y/o crítico

    Medicina Intensiva, Vol. 39, Núm. 9, pp. 552-562

  2. Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar

    Journal of the American College of Cardiology, Vol. 65, Núm. 19, pp. 2057-2066

2013

  1. Intravenous administration of tranexamic acid to decrease bleeding and transfusion in knee and hip prosthetic surgery: Is it safe and cost-effective?

    Medicina Clinica, Vol. 141, Núm. 5, pp. 207-209